HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART

EBioMedicine

Volumn 11, Issue , 2016, Pages 68-72

  Ananworanich, Jintanat ^a,b,c   Chomont, Nicolas ^d,e   Eller, Leigh Ann ^a,b   Kroon, Eugene ^c,f   Tovanabutra, Sodsai ^a,b   Bose, Meera ^a,b   Nau, Martin ^a,b   Fletcher, James L K ^c   Tipsuk, Somporn ^c   Vandergeeten, Claire ^e   O'Connell, Robert J ^d   Pinyakorn, Suteeraporn ^a,b   Michael, Nelson ^a   Phanuphak, Nittaya ^c   Robb, Merlin L ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e Vaccine and Gene Therapy Institute of Florida   (United States)

^f ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

Acute HIV infection; Art; HIV DNA; Persistence; Reservoir

Indexed keywords

EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EFAVIRENZ PLUS LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; MARAVIROC; RALTEGRAVIR; VIRUS DNA; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; CLASSIFICATION; GENOTYPE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; PHYSIOLOGY; PROVIRUS; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PROVIRUSES; RNA, VIRAL; VIRAL LOAD; YOUNG ADULT;

EID: 84994860400     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.07.024     Document Type: Article

References (30)

1. Ananworanich, J., Fauci, A.S., HIV cure research: a formidable challenge. J. Virus Erad. 1 (2015), 1–3.
2. Ananworanich, J., Schuetz, A., Vandergeeten, C., Sereti, I., De Souza, M., Rerknimitr, R., Dewar, R., Marovich, M., van Griensven, F., Sekaly, R., Pinyakorn, S., Phanuphak, N., Trichavaroj, R., Rutvisuttinunt, W., Chomchey, N., Paris, R., Peel, S., Valcour, V., Maldarelli, F., Chomont, N., Michael, N., Phanuphak, P., Kim, J.H., Group, R. S. S., Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One, 7, 2012, e33948.
3. Ananworanich, J., Fletcher, J.L., Pinyakorn, S., van Griensven, F., Vandergeeten, C., Schuetz, A., Pankam, T., Trichavaroj, R., Akapirat, S., Chomchey, N., Phanuphak, P., Chomont, N., Michael, N.L., Kim, J.H., de Souza, M., Group, R. S. S., A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology, 10, 2013, 56.
4. Ananworanich, J., Chomont, N., Fletcher, J.L., Pinyakorn, S., Schuetz, A., Sereti, I., Rerknimitr, R., Dewar, R., Kroon, E., Vandergeeten, C., Trichavaroj, R., Chomchey, N., Chalermchai, T., Michael, N.L., KIM, J.H., Phanuphak, P., Phanuphak, N., Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification. J. Virus Erad. 1 (2015), 116–122.
5. Buzon, M.J., Martin-Gayo, E., Pereyra, F., Ouyang, Z., Sun, H., Li, J.Z., Piovoso, M., Shaw, A., Dalmau, J., Zangger, N., Martinez-Picado, J., Zurakowski, R., Yu, X.G., Telenti, A., Walker, B.D., Rosenberg, E.S., Lichterfeld, M., Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J. Virol. 88 (2014), 10056–10065.
6. Cheret, A., Bacchus-Souffan, C., Avettand-Fenoel, V., Melard, A., Nembot, G., Blanc, C., Samri, A., Saez-Cirion, A., Hocqueloux, L., Lascoux-Combe, C., Allavena, C., Goujard, C., Valantin, M.A., Leplatois, A., Meyer, L., Rouzioux, C., Autran, B., GROUP, O. A.-S., Combined ART started during acute HIV infection protects central memory CD4 + T cells and can induce remission. J. Antimicrob. Chemother. 70 (2015), 2108–2120.
7. Cone, R.W., Gowland, P., Opravil, M., Grob, P., Ledergerber, B., Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection. Swiss HIV Cohort Study. AIDS 12 (1998), 2253–2260.
8. de Souza, M.S., Phanuphak, N., Pinyakorn, S., Trichavaroj, R., Pattanachaiwit, S., Chomchey, N., Fletcher, J.L., Kroon, E.D., Michael, N.L., Phanuphak, P., Kim, J.H., Ananworanich, J., Group, R. S. S., Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection. AIDS 29 (2015), 793–800.
9. Eriksson, S., Graf, E.H., Dahl, V., Strain, M.C., Yukl, S.A., Lysenko, E.S., Bosch, R.J., Lai, J., Chioma, S., Emad, F., Abdel-Mohsen, M., Hoh, R., Hecht, F., Hunt, P., Somsouk, M., Wong, J., Johnston, R., Siliciano, R.F., Richman, D.D., O'Doherty, U., Palmer, S., Deeks, S.G., Siliciano, J.D., Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog., 9, 2013, e1003174.
10. Fiebig, E.W., Wright, D.J., Rawal, B.D., Garrett, P.E., Schumacher, R.T., Peddada, L., Heldebrant, C., Smith, R., Conrad, A., Kleinman, S.H., Busch, M.P., Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17 (2003), 1871–1879.
11. Goujard, C., Bonarek, M., Meyer, L., Bonnet, F., Chaix, M.L., Deveau, C., Sinet, M., Galimand, J., Delfraissy, J.F., Venet, A., Rouzioux, C., Morlat, P., Agence Nationale de Recherche sur le Sida, P. S. G., CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin. Infect. Dis. 42 (2006), 709–715.
12. Groves, K.C., Bibby, D.F., Clark, D.A., Isaksen, A., Deayton, J.R., Anderson, J., Orkin, C., Stagg, A.J., Mcknight, A., Disease progression in HIV-1-infected viremic controllers. J. Acquir. Immune Defic. Syndr. 61 (2012), 407–416.
13. Henrich, T.J., Hanhauser, E., Marty, F.M., Sirignano, M.N., Keating, S., Lee, T.H., Robles, Y.P., Davis, B.T., Li, J.Z., Heisey, A., Hill, A.L., Busch, M.P., Armand, P., Soiffer, R.J., Altfeld, M., Kuritzkes, D.R., Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann. Intern. Med. 161 (2014), 319–327.
14. Hill, A.L., Rosenbloom, D.I., Fu, F., Nowak, M.A., Siliciano, R.F., Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 13475–13480.
15. Jain, V., Hartogensis, W., Bacchetti, P., Hunt, P.W., Hatano, H., Sinclair, E., Epling, L., Lee, T.H., Busch, M.P., Mccune, J.M., Pilcher, C.D., Hecht, F.M., Deeks, S.G., Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J. Infect. Dis. 208 (2013), 1202–1211.
16. Kiselinova, M., de Spiegelaere, W., Buzon, M.J., Malatinkova, E., Lichterfeld, M., Vandekerckhove, L., Integrated and Total HIV-1 DNA predict ex vivo viral outgrowth. PLoS Pathog., 12, 2016, e1005472.
17. Kulpa, D.A., Chomont, N., HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?. J. Virus Erad. 1 (2015), 59–66.
18. Laanani, M., Ghosn, J., Essat, A., Melard, A., Seng, R., Gousset, M., PANJO, H., Mortier, E., Girard, P.M., Goujard, C., Meyer, L., Rouzioux, C., Agence Nationale de Recherche sur le SIDA, P. C. S. G., Impact of the timing of initiation of antiretroviral therapy during primary HIV-1 infection on the decay of cell-associated HIV-DNA. Clin. Infect. Dis. 60 (2015), 1715–1721.
19. Li, J.Z., Etemad, B., Ahmed, H., Aga, E., Bosch, R.J., Mellors, J.W., Kuritzkes, D.R., Lederman, M.M., Para, M., Gandhi, R.T., The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS 30 (2016), 343–353.
20. Lorenzo-Redondo, R., Fryer, H.R., Bedford, T., Kim, E.Y., Archer, J., Kosakovsky Pond, S.L., Chung, Y.S., Penugonda, S., Chipman, J.G., Fletcher, C.V., Schacker, T.W., Malim, M.H., Rambaut, A., Haase, A.T., Mclean, A.R., Wolinsky, S.M., Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530 (2016), 51–56.
21. Martin, A.R., Siliciano, R.F., Progress toward HIV eradication: case reports, current efforts, and the challenges associated with cure. Annu. Rev. Med. 67 (2016), 215–228.
22. Persaud, D., Luzuriaga, K., Absence of HIV-1 after treatment cessation in an infant. N. Engl. J. Med., 370, 2014, 678.
23. Robb, M.L., Eller, L.A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F.K., Sinei, S., Sriplienchan, S., Jagodzinski, L.L., Malia, J., Manak, M., de Souza, M.S., Tovanabutra, S., Sanders-Buell, E., Rolland, M., Dorsey-Spitz, J., Eller, M.A., Milazzo, M., LI, Q., Lewandowski, A., Wu, H., Swann, E., O'Connell, R.J., Peel, S., Dawson, P., Kim, J.H., Michael, N.L., Team, R. V. S., Prospective study of acute HIV-1 infection in adults in East Africa and Thailand. N. Engl. J. Med. 374 (2016), 2120–2130.
24. Rothenberger, M.K., Keele, B.F., Wietgrefe, S.W., Fletcher, C.V., Beilman, G.J., Chipman, J.G., Khoruts, A., Estes, J.D., Anderson, J., Callisto, S.P., Schmidt, T.E., Thorkelson, A., Reilly, C., Perkey, K., Reimann, T.G., Utay, N.S., Nganou Makamdop, K., Stevenson, M., Douek, D.C., Haase, A.T., Schacker, T.W., Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E1126–E1134.
25. Rouzioux, C., Hubert, J.B., Burgard, M., Deveau, C., Goujard, C., Bary, M., Sereni, D., Viard, J.P., Delfraissy, J.F., Meyer, L., GROUP, S. C. S., Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4 + T cell counts. J. Infect. Dis. 192 (2005), 46–55.
26. Saez-Cirion, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., Descours, B., Guergnon, J., Viard, J.P., Boufassa, F., Lambotte, O., Goujard, C., Meyer, L., Costagliola, D., Venet, A., Pancino, G., Autran, B., Rouzioux, C., Group, A. V. S., Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLoS Pathog., 9, 2013, e1003211.
27. Siliciano, J.D., Siliciano, R.F., Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1. J. Allergy Clin. Immunol. 134 (2014), 12–19.
28. Vandergeeten, C., Fromentin, R., Merlini, E., Lawani, M.B., Dafonseca, S., Bakeman, W., McNulty, A., Ramgopal, M., Michael, N., KIM, J.H., Ananworanich, J., Chomont, N., Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies. J. Virol. 88 (2014), 12385–12396.
29. Viard, J.P., Burgard, M., Hubert, J.B., Aaron, L., Rabian, C., Pertuiset, N., Lourenco, M., Rothschild, C., Rouzioux, C., Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 18 (2004), 45–49.
30. Williams, J.P., Hurst, J., Stohr, W., Robinson, N., Brown, H., Fisher, M., Kinloch, S., Cooper, D., Schechter, M., Tambussi, G., Fidler, S., Carrington, M., Babiker, A., Weber, J., Koelsch, K.K., Kelleher, A.D., Phillips, R.E., Frater, J., Investigators, S. P., HIV-1 DNA predicts disease progression and post-treatment virological control. Elife, 3, 2014, e03821.